Opportunity Overview
Two such approaches are biological control using viruses which specifically target bacteria (bacteriophages) and antimicrobial peptides (AMPs). Both approaches have unique advantages over antibiotics. Bacteriophage are self-replicating and self-limiting - reproducing only when susceptible bacteria are present. Unlike broad-spectrum antibiotics, they target a specific genus, species or strain of bacterium, avoiding potentially harmful dysbiosis in the patient.
AMPs form the basis of effective innate immune responses to bacteria and other micro-organisms in all classes of life. The most common mode of action of these to bacterial cells is thought to be via a destabilisation of the bacterial cell membrane resulting in cell lysis. AMPs can vary in size from less than 10aas to 60-70aas, their small size enabling rapid diffusion, and penetration/destabilisation of bacterial biofilms.
In this project we aim to combine the strengths of both approaches to control SI, with the ultimate aim of using this combination therapy in poultry, and potentially as a model for use in human medicine.
The PhD study is divided into two strands:
1. Isolation and characterisation of antimicrobial peptides (AMPs) specifically targeting SI.
Next Generation Peptide Phage Display (NGPD) will be used to isolate or modify peptides specifically targeting the surface of...
This is one of 2,051 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | BBSRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2023 |
| Procurement stage | Active solicitation |
| Response due | September 29, 2027 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | September 21, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.